Mary L McMaster

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenström macroglobulinemia
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD MD 20892 7236, USA
    Int J Cancer 122:1183-8. 2008
  2. pmc Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Clin Lymphoma Myeloma 9:19-22. 2009
  3. ncbi request reprint Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition
    Mary L McMaster
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Br J Haematol 139:663-71. 2007
  4. ncbi request reprint Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NIH, Department of Health and Human Services, 6120 Executive Boulevard, MSC 7236 Bethesda, MD 20892 7236, USA
    Clin Cancer Res 13:5063-9. 2007
  5. pmc Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families
    Mary L McMaster
    Genetic Epidemiology Branch, Bethesda, MD, 20892 7236, USA
    Am J Hum Genet 79:695-701. 2006
  6. ncbi request reprint Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition
    Mary L McMaster
    Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health DHHS, 6120 Executive Boulevard, Bethesda, MD 20892, USA
    Clin Lymphoma 5:230-4. 2005
  7. pmc Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation
    Regan H Royer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 115:4464-71. 2010
  8. ncbi request reprint Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Int J Cancer 118:3095-8. 2006
  9. pmc Chronic immune stimulation and subsequent Waldenström macroglobulinemia
    Jill Koshiol
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, and Division of Genetic Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd, EPS 7003, MSC 7236, Bethesda, MD 20892 7236, USA
    Arch Intern Med 168:1903-9. 2008
  10. doi request reprint Prevalence, clinical aspects, and natural history of IgM MGUS
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7236, USA
    Cytometry B Clin Cytom 78:S91-7. 2010

Detail Information

Publications21

  1. ncbi request reprint Protein electrophoresis, immunoelectrophoresis and immunofixation electrophoresis as predictors for high-risk phenotype in familial Waldenström macroglobulinemia
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD MD 20892 7236, USA
    Int J Cancer 122:1183-8. 2008
    ..Polyclonal IgM may also be a marker of genetic susceptibility in WM families. Larger studies are needed to confirm these observations...
  2. pmc Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Clin Lymphoma Myeloma 9:19-22. 2009
    ..Large collaborative studies are needed to confirm these findings, which present an opportunity to define the earliest lesion(s) in the WM oncogenic pathway...
  3. ncbi request reprint Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition
    Mary L McMaster
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Br J Haematol 139:663-71. 2007
    ....
  4. ncbi request reprint Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NIH, Department of Health and Human Services, 6120 Executive Boulevard, MSC 7236 Bethesda, MD 20892 7236, USA
    Clin Cancer Res 13:5063-9. 2007
    ....
  5. pmc Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families
    Mary L McMaster
    Genetic Epidemiology Branch, Bethesda, MD, 20892 7236, USA
    Am J Hum Genet 79:695-701. 2006
    ..The findings from this first linkage analysis of families at high risk for WM represent important progress toward identifying gene(s) that modulate susceptibility to WM and toward understanding its complex etiology...
  6. ncbi request reprint Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition
    Mary L McMaster
    Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health DHHS, 6120 Executive Boulevard, Bethesda, MD 20892, USA
    Clin Lymphoma 5:230-4. 2005
    ....
  7. pmc Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation
    Regan H Royer
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Blood 115:4464-71. 2010
    ..69-10.51) compared with unaffected family members. These data provide clues to both genetic and environmental factors that may influence development of WM. Well-designed case-control studies are needed to confirm these findings...
  8. ncbi request reprint Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA
    Int J Cancer 118:3095-8. 2006
    ..However, MM itself shows significant familial aggregation, implicating the etiologic importance of this type of hematological neoplasm and perhaps MGUS in germ line genes...
  9. pmc Chronic immune stimulation and subsequent Waldenström macroglobulinemia
    Jill Koshiol
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, and Division of Genetic Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd, EPS 7003, MSC 7236, Bethesda, MD 20892 7236, USA
    Arch Intern Med 168:1903-9. 2008
    ..A few previous studies suggest that chronic inflammation may particularly elevate risk of the distinct non-Hodgkin lymphoma subtype Waldenström macroglobulinemia (WM)...
  10. doi request reprint Prevalence, clinical aspects, and natural history of IgM MGUS
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7236, USA
    Cytometry B Clin Cytom 78:S91-7. 2010
    ..Recently, a case of MBL with an IgM MGUS was reported, suggesting a close biological relationship between these entities. While much is known about MGUS overall, investigations of IgM MGUS specifically have been fragmentary...
  11. ncbi request reprint Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
    Lois B Travis
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 97:1354-65. 2005
    ..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors...
  12. pmc Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005
    Porcia T Bradford
    Genetic Epidemiology Branch, DCEG, NCI, NIH, 6120 Executive Blvd, Room 7005, Rockville, MD 20852 7236, USA
    Arch Dermatol 145:427-34. 2009
    ..To examine incidence and survival patterns of acral lentiginous melanoma (ALM) in the United States...
  13. ncbi request reprint Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples
    Lynn R Goldin
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7236, Bethesda, MD 20892 7236, USA
    Cancer Epidemiol Biomarkers Prev 14:2402-6. 2005
    ..We estimate that the absolute lifetime risk for a first-degree relative of an NHL case to develop NHL is 3.6% (compared with a population risk of 2.1%) and higher if the index case had an aggressive subtype of NHL...
  14. ncbi request reprint Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana
    Ola Landgren
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Bldg EPS Room 7110, Bethesda, MD 20892 7236, USA
    Mayo Clin Proc 82:1468-73. 2007
    ....
  15. ncbi request reprint Familial Waldenstrom's macroglobulinemia
    Mary L McMaster
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Semin Oncol 30:146-52. 2003
    ..Although limited by small numbers and a lack of systematic ascertainment and evaluation, these data are intriguing and provide a compelling basis for further study and systematic investigation of WM in families...
  16. pmc Precursors to lymphoproliferative malignancies
    Lynn R Goldin
    Corresponding Author Lynn R Goldin, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, 6120 Executive Blvd, Bethesda, MD 20892
    Cancer Epidemiol Biomarkers Prev 22:533-9. 2013
    ..A key focus for current work is to identify markers that predict progression to malignancy. Cancer Epidemiol Biomarkers Prev; 22(4); 533-9. ©2013 AACR...
  17. pmc Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population
    Mary L McMaster
    Genetic Epidemiology Branch, Human Genetics Program, Division of Cancer Epidemiologyand Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    J Med Genet 48:444-9. 2011
    ..Reports of chordoma in children with TSC suggest that TSC1 and TSC2 mutations may contribute to chordoma aetiology...
  18. pmc Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden
    Sigurdur Y Kristinsson
    Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden
    Blood 112:3052-6. 2008
    ..Our findings of highly increased risks of developing LPL/WM, NHL, CLL, and MGUS support the operation of shared susceptibility genes that predispose to LPL/WM and other lymphoproliferative disorders...
  19. ncbi request reprint Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men
    Sophie D Fossa
    Department of Clinical Cancer Research, The Norwegian Radium Hospital, University of Oslo, Norway
    J Natl Cancer Inst 97:1056-66. 2005
    ..We evaluated the risk of contralateral testicular cancer and survival in a large population-based cohort of men diagnosed with testicular cancer before age 55 years...
  20. ncbi request reprint No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia
    David Ng
    Br J Haematol 137:173-5. 2007
  21. ncbi request reprint Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
    Roger G Owen
    Leeds General Infirmary, Leeds, UK
    Semin Oncol 30:110-5. 2003
    ..Patients with clinical features attributable to IgM monoclonal gammopathy but no overt evidence of lymphoma are considered to constitute a distinct clinical group and the term "IgM-related disorders" is proposed...